BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/1/2026 7:49:44 AM | Browse: 6 | Download: 0
Publication Name World Journal of Cardiology
Manuscript ID 119100
Country United States
Category Pharmacology & Pharmacy
Manuscript Type Meta-Analysis
Article Title Cardiovascular safety of proton pump inhibitors in post-percutaneous coronary intervention patients receiving dual antiplatelet therapy: A meta-analysis
Manuscript Source Unsolicited Manuscript
All Author List Rohab Sohail, Zaraq Khan, Haider Hussain Shah, Ridda Khattak, Azeem Khan, Shahryar Chaudhry, Uzair Khan, Hafsa Mansoor, Fnu Namal, Jason Orciuolo, Sahil Desai and Manjeet Singh
Funding Agency and Grant Number
Corresponding Author Rohab Sohail, MD, Internal Medicine, Bayhealth Medical Center, 640 South State Street, Dover, DE 19904, United States. rohabsohail98@gmail.com
Key Words Proton pump inhibitors; Dual antiplatelet therapy; Percutaneous coronary intervention; Major cardiovascular adverse events; Cardiac revascularization
Core Tip This meta-analysis provides a robust, clinically relevant evaluation of proton pump inhibitor use in patients receiving dual antiplatelet therapy after PCI by integrating evidence from both randomized trials and real-world observational studies. Importantly, it demonstrates that concerns regarding impaired antiplatelet efficacy do not translate into increased risks of acute coronary syndrome, mortality, stent thrombosis, or stroke in randomized data, suggesting that adverse signals seen in observational studies likely reflect residual confounding rather than true harm. These findings shift the focus from theoretical drug–drug interactions to patient-centered clinical outcomes and support the safe, guideline-concordant use of PPIs for gastrointestinal protection in appropriately selected post-PCI patients.
Citation Sohail R, Khan Z, Shah HH, Khattak R, Khan A, Chaudhry S, Khan U, Mansoor H, Namal F, Orciuolo J, Desai S, Singh M. Cardiovascular safety of proton pump inhibitors in post-percutaneous coronary intervention patients receiving dual antiplatelet therapy: A meta-analysis. World J Cardiol 2026; In press
Received
2026-01-19 03:45
Peer-Review Started
2026-01-19 10:15
First Decision by Editorial Office Director
2026-02-02 08:58
Return for Revision
2026-02-02 08:58
Revised
2026-02-10 23:36
Publication Fee Transferred
2026-02-12 20:12
Second Decision by Editor
2026-04-01 02:44
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-04-01 07:49
Articles in Press
2026-04-01 07:49
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1949-8462 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © Author(s) (or their employer(s)) 2026. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com